# Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

> **NCT03488420** · — · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 136 (actual)

## Conditions studied

- Atrial Fibrillation and Flutter
- Valvular Heart Disease

## Interventions

- **DRUG:** Edoxaban Pill

## Key facts

- **NCT ID:** NCT03488420
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2025-03-21
- **Final completion:** 2025-04-03
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03488420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03488420, "Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03488420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*